Anti-L-selectin monoclonal antibody - Abgenix

Drug Profile

Anti-L-selectin monoclonal antibody - Abgenix

Alternative Names: DREG 200 - Abgenix

Latest Information Update: 25 Jul 2000

Price : $50

At a glance

  • Originator Abgenix
  • Class
  • Mechanism of Action L-selectin inhibitors
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Inflammation

Most Recent Events

  • 25 Jul 2000 Discontinued-Preclinical for Inflammation in USA (Unknown route)
  • 06 May 1997 Preclinical development for Inflammation in USA (Unknown route)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top